[1]Cho, S. S., Qi, L., Fahey, G. C., Jr., Klurfeld, D. M., Consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease. The American journal of clinical nutrition 2013, 98, 594-619.
[2]刘会省 , 王彦明, 任文秀.燕麦营养成分研究进展[J].现代食品,2021(06):127-130+141.
[3]任长忠, 闫金婷, 董锐等.燕麦营养成分、功能特性及其产品的研究进展[J].食品工业科技,2022,43(12):438-446.
[4]姚望,彭毛,姚芬.燕麦生物活性成分及生理功能研究进展[J].粮食与油脂,2020,33(08):11-14.
[5]Xie X ,Lin M ,Xiao G , et al. Phenolic amides (avenanthramides) in oats - an update review. [J]. Bioengineered, 2024, 15 (1): 2305029-2305029.
[6]吴玉杰, 袁娟丽, 陈红兵.燕麦生物碱的结构与功能研究进展[J].食品工业科技,2018,39(15):328-333.
[7]武娇.燕麦生物碱合成的诱导调控研究[D].山西农业大学,2015.
[8]唐娅茹,王力伟,安江红等.燕麦生物碱的研究进展与应用[J].北方农业学报,2023,51(06):37-50.
[9]Dimberg, L. H., Gissen, C., Nilsson, J., Phenolic compounds in oat grains (Avena sativa L.) grown in conventional and organic systems. Ambio 2005,34,331-337.
[10]Peterson DM, Emmons CL & Hibbs AH (2001) Phenolic antioxidants and antioxidant activity in pearling fractions of oat groats. J Cereal Sci 33, 97 – 103.
[11]Dimberg, L. H., Molteberg, E. L., Solheim, R., Frolich, W., Variation in oat groats due to variety, storage and heat treatment .1. Phenolic compounds. J Cereal Sci 1996, 24, 263-272.
[12]Dimberg, L. H., Sunnerheim, K., Sundberg, B., Walsh, K., Stability of oat avenanthramides. Cereal Chem 2001, 78, 278-281.
[13]Bryngelsson, S., Dimberg, L. H., Kamal-Eldin, A., Effects of commercial processing on levels of antioxidants in oats (Avena sativa L.). J Agric Food Chem 2002, 50, 1890-1896.
[14]Bryngelsson, S., Ishihara, A., Dimberg, L. H., Levels of avenanthramides and activity of hydroxycinnamoyl-CoA: Hydroxyanthranilate N-hydroxycinnamoyl transferase (HHT) in steeped or germinated oat samples. Cereal Chem 2003, 80, 356-360.
[15]Lee-Manion AM, Price RK, Strain JJ, et al. In vitro antioxidant activity and antigenotoxic effects of avenanthramides and related compounds. J Agric Food Chem. 2009;57:10619–10624.
[16]Dimberg, L. H., Theander, O., Lingnert, H., Avenanthramides - a Group of Phenolic Antioxidants in Oats. Cereal Chem 1993, 70, 637-641.
[17]Yang, J., Ou, B. X., Wise, M. L., Chu, Y. F., In vitro total antioxidant capacity and antiinflammatory activity of three common oat-derived avenanthramides. Food Chem 2014, 160, 338-345.
[18]Ji LL, Lay D, Chung E, et al. Effects of avenanthramides on oxidant generation and antioxidant enzyme activity in exercised rats. Nutr Res. 2003;23(11):1579–1590.
[19]Chen CYO, Milbury PE, Collins FW, et al. Avenanthramides are bioavailable and have antioxidant activity in humans after acute consumption of an enriched mixture from oats. J Nutr. 2007;137:1375–1382.
[20]Ren Y, Yang X, Niu X, et al. Chemical characterization of the avenanthramide-rich extract from oat and its effect on d-galactose-induced oxidative stress in mice. J Agric Food Chem. 2011;59:206–211. doi: 10.1021/jf103938e
[21]Landberg R, Sunnerheim K, Dimberg LH. Avenanthramides as lipoxygenase inhibitors. Heliyon. 2020;6:e04304. doi: 10.1016/j.heliyon.2020.e04304
[22]Liu, S., Yang, N., Hou, Z. H., Yao, Y., et al., Antioxidant Effects of Oats Avenanthramides on Human Serum. Agric. Sci. China 2011, 10, 1301-1305.
[23]Koenig, R., Dickman, J. R., Kang, C. H., Zhang, T. O., et al., Avenanthramide supplementation attenuates exercise-induced inflammation in postmenopausal women. Nutr J 2014, 13.
[24]Chen, C. Y., Milbury, P. E., Kwak, H. K., Collins, F. W., et al., Avenanthramides and phenolic acids from oats are bioavailable and act synergistically with vitamin C to enhance hamster and human LDL resistance to oxidation. J Nutr 2004, 134, 1459-1466.
[25]Meydani, M., Potential health benefits of avenanthramides of oats. Nutr Rev 2009, 67, 731- 735.
[26]Guo, W., Wise, M. L., Collins, F. W., Meydani, M., Avenanthramides, polyphenols from oats, inhibit IL-1 beta-induced NF-kappa B activation in endothelial cells. Free Radical Bio Med 2008, 44, 415-429.
[27]Boz H. Phenolic amides (avenanthramides) in oats - a review. Czech J Food Sci. 2015;33:399–404.
[28]任祎,马挺军,崔林.燕麦生物碱及其潜在的保健作用[J].中国粮油学报,2012,27(01):124-128.
[29]Nie L, Wise M, Peterson D, Meydani M. Mechanism by which avenanthramide-c, a polyphenol of oats, blocks cell cycle progression in vascular smooth muscle cells. Free Radic Biol Med. 2006;41:702–708.
[30]Guo, W. M., Nie, L., Wu, D. Y., Wise, M. L., et al., Avenanthramides Inhibit Proliferation of Human Colon Cancer Cell Lines In Vitro. Nutr. Cancer 2010, 62, 1007-1016.
[31]Antonini, E.; Iori, R.; Ninfali, P.; Scarpa, E.S. A Combination of Moringin and Avenanthramide 2f Inhibits the Proliferation of Hep3B Liver Cancer Cells Inducing Intrinsic and Extrinsic Apoptosis. Nutr. Cancer 2018, 70,1159–1165.
[32]Scarpa, E.S.; Antonini, E.; Palma, F.; Mari, M.; Ninfali, P. Antiproliferative activity of vitexin-2-O-xyloside and avenanthramides on CaCo-2 and HepG2 cancer cells occurs through apoptosis induction and reduction of pro-survival mechanisms. Eur. J. Nutr. 2018, 57, 1381–1395.
[33]Wu, W.; Tang, Y.; Yang, J.; Idehen, E.; Sang, S. Avenanthramide Aglycones and Glucosides in Oat Bran:Chemical Profile, Levels in Commercial Oat Products, and Cytotoxicity to Human Colon Cancer Cells.J. Agric. Food Chem. 2018, 66, 8005–8014.
[34]Fu, R.; Yang, P.; Amin, S.; Li, Z. Avenanthramide A induces cellular senescence via miR-129-3p/Pirh2/p53signaling pathway to suppress colon cancer growth. J. Agric. Food Chem. 2019, 67, 4808–4816.
[35]Visone, R.; Croce, C.M. MiRNAs and cancer. Am. J. Pathol. 2009, 174, 1131–1138.
[36]Prieto-Garcia, E.; Diaz-Garcia, C.V.; Garcia-Ruiz, I.; Agullo-Ortuno, M.T.Epithelial-to-mesenchymal transitionin tumor progression. Med. Oncol. 2017, 34, 122.
[37]Finetti, F.; Moglia, A.; Schiavo, I.; Donnini, S.; Berta, G.N.; Di Scipio, F.; Perrelli, A.; Fornelli, C.; Trabalzini, L.;Retta, S.F. Yeast-Derived Recombinant Avenanthramides Inhibit Proliferation, Migration and Epithelial Mesenchymal Transition of Colon Cancer Cells. Nutrients 2018, 10, 1159.
[38]Wang, D.; Wise, M.L.; Li, F.; Dey, M. Phytochemicals attenuating aberrant activation of beta-catenin in cancer cells. PLoS ONE 2012, 7, e50508.
[39]Wang, S.C. PCNA: A silent housekeeper or a potential therapeutic target? Trends Pharmacol. Sci. 2014, 35,178–186.